130 related articles for article (PubMed ID: 37639758)
21. A novel class of antitumor prodrug, 1-(2'-oxopropyl)-5-fluorouracil (OFU001), that releases 5-fluorouracil upon hypoxic irradiation.
Shibamoto Y; Zhou L; Hatta H; Mori M; Nishimoto S
Jpn J Cancer Res; 2000 Apr; 91(4):433-8. PubMed ID: 10804292
[TBL] [Abstract][Full Text] [Related]
22. [Lethal drug interactions of the new antiviral, sorivudine, with anticancer prodrugs of 5-fluorouracil].
Watabe T; Okuda H; Ogura K
Yakugaku Zasshi; 1997 Nov; 117(10-11):910-21. PubMed ID: 9414600
[TBL] [Abstract][Full Text] [Related]
23. Anticancer activity of an extract from needles and twigs of Taxus cuspidata and its synergistic effect as a cocktail with 5-fluorouracil.
Shang W; Qiao J; Gu C; Yin W; Du J; Wang W; Zhu M; Han M; Lu W
BMC Complement Altern Med; 2011 Dec; 11():123. PubMed ID: 22132732
[TBL] [Abstract][Full Text] [Related]
24. Adenosine potentiates the therapeutic effects of neural stem cells expressing cytosine deaminase against metastatic brain tumors.
Kang W; Seol HJ; Seong DH; Kim J; Kim Y; Kim SU; Nam DH; Joo KM
Oncol Rep; 2013 Sep; 30(3):1101-6. PubMed ID: 23828015
[TBL] [Abstract][Full Text] [Related]
25. Novel 5-fluorouracil complexes of Zn(II) with pyridine-based ligands as potential anticancer agents.
Icsel C; Yilmaz VT; Aygun M; Erkisa M; Ulukaya E
Dalton Trans; 2022 Mar; 51(13):5208-5217. PubMed ID: 35275157
[TBL] [Abstract][Full Text] [Related]
26. [Timeline from discovery of 5-FU to development of an oral anticancer agent S-1 and its drug concept].
Shirasaka T; Taguchi T
Gan To Kagaku Ryoho; 2006 Jun; 33 Suppl 1():4-18. PubMed ID: 16897967
[TBL] [Abstract][Full Text] [Related]
27. Design, synthesis, and evaluation of novel mutual prodrugs (hybrid drugs) of all-trans-retinoic acid and histone deacetylase inhibitors with enhanced anticancer activities in breast and prostate cancer cells in vitro.
Gediya LK; Khandelwal A; Patel J; Belosay A; Sabnis G; Mehta J; Purushottamachar P; Njar VC
J Med Chem; 2008 Jul; 51(13):3895-904. PubMed ID: 18543902
[TBL] [Abstract][Full Text] [Related]
28. Inclusion of a 5-fluorouracil moiety in nitrogenous bases derivatives as human carbonic anhydrase IX and XII inhibitors produced a targeted action against MDA-MB-231 and T47D breast cancer cells.
Petreni A; Bonardi A; Lomelino C; Osman SM; ALOthman ZA; Eldehna WM; El-Haggar R; McKenna R; Nocentini A; Supuran CT
Eur J Med Chem; 2020 Mar; 190():112112. PubMed ID: 32044580
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Fatty Acid Synthase (FASN) synergistically enhances the efficacy of 5-fluorouracil in breast carcinoma cells.
Vazquez-Martin A; Ropero S; Brunet J; Colomer R; Menendez JA
Oncol Rep; 2007 Oct; 18(4):973-80. PubMed ID: 17786362
[TBL] [Abstract][Full Text] [Related]
30. DMAKO-20 as a New Multitarget Anticancer Prodrug Activated by the Tumor Specific CYP1B1 Enzyme.
Cui J; Zhang X; Huang G; Zhang Q; Dong J; Sun G; Meng Q; Li S
Mol Pharm; 2019 Jan; 16(1):409-421. PubMed ID: 30481041
[TBL] [Abstract][Full Text] [Related]
31. Synergistic antitumor effect of dichloroacetate in combination with 5-fluorouracil in colorectal cancer.
Tong J; Xie G; He J; Li J; Pan F; Liang H
J Biomed Biotechnol; 2011; 2011():740564. PubMed ID: 21403907
[TBL] [Abstract][Full Text] [Related]
32. Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.
Raymond E; Buquet-Fagot C; Djelloul S; Mester J; Cvitkovic E; Allain P; Louvet C; Gespach C
Anticancer Drugs; 1997 Oct; 8(9):876-85. PubMed ID: 9402315
[TBL] [Abstract][Full Text] [Related]
33. Preparation and Bioactivity Assessment of Chitosan-1-Acetic Acid-5-Flurouracil Conjugates as Cancer Prodrugs.
Mohammed MO; Hussain KS; Haj NQ
Molecules; 2017 Nov; 22(11):. PubMed ID: 29117097
[TBL] [Abstract][Full Text] [Related]
34. Water-soluble copper(II) 5-fluorouracil complexes bearing polypyridyl co-ligands: synthesis, structures and anticancer activity.
Icsel C; Yilmaz VT; Aygun M; Erkisa M; Ulukaya E
Dalton Trans; 2023 May; 52(21):7048-7058. PubMed ID: 36939483
[TBL] [Abstract][Full Text] [Related]
35. Novel Benzyloxyphenyl Pyrimidine-5-Carbonitrile Derivatives as Potential Apoptotic Antiproliferative Agents.
Al-Mahmoudy A; Hassan A; Ibrahim T; Youssif BGM; Taher E; Tantawy M; Abdel-Aal E; Osman N
Anticancer Agents Med Chem; 2022; 22(5):978-990. PubMed ID: 34126912
[TBL] [Abstract][Full Text] [Related]
36. Development of new promising antimetabolite, DFP-11207 with self-controlled toxicity in rodents.
Fukushima M; Iizuka K; Jin C; Zhang C; Hong M; Eshima K
Drug Des Devel Ther; 2017; 11():1693-1705. PubMed ID: 28652707
[TBL] [Abstract][Full Text] [Related]
37. Dichloroacetate attenuates hypoxia-induced resistance to 5-fluorouracil in gastric cancer through the regulation of glucose metabolism.
Xuan Y; Hur H; Ham IH; Yun J; Lee JY; Shim W; Kim YB; Lee G; Han SU; Cho YK
Exp Cell Res; 2014 Feb; 321(2):219-30. PubMed ID: 24342832
[TBL] [Abstract][Full Text] [Related]
38. Efficacy of Antineoplastic Nanocarriers on 3D Oral Cancer Spheroids.
Mendoza-Martinez NL; Cadena-Galeana AD; Villanueva-Sanchez FG; Perez-Cornejo N; Avelar-Juarez KM; Ramos-Baena JD; Cruz-Monroy EA; Vazquez-Zuniga U; Garcia-Contreras R
In Vivo; 2023; 37(4):1658-1665. PubMed ID: 37369492
[TBL] [Abstract][Full Text] [Related]
39. DCA increases the antitumor effects of capecitabine in a mouse B16 melanoma allograft and a human non-small cell lung cancer A549 xenograft.
Zheng MF; Shen SY; Huang WD
Cancer Chemother Pharmacol; 2013 Nov; 72(5):1031-41. PubMed ID: 24043136
[TBL] [Abstract][Full Text] [Related]
40. Traceable Nanocluster-Prodrug Conjugate for Chemo-photodynamic Combinatorial Therapy of Non-small Cell Lung Cancer.
Srinivasulu YG; Mozhi A; Goswami N; Yao Q; Xie J
ACS Appl Bio Mater; 2021 Apr; 4(4):3232-3245. PubMed ID: 35014410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
